Black Rock Inc. Biogen Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Black Rock Inc. holds 14,144,988 shares of BIIB stock, worth $3.28 Billion. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,144,988
Previous 14,246,658
0.71%
Holding current value
$3.28 Billion
Previous $3.69 Billion
17.27%
% of portfolio
0.07%
Previous 0.1%
Shares
12 transactions
Others Institutions Holding BIIB
# of Institutions
1,046Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.84 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.76 Billion2.65% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.56 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.2 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA5.12MShares$1.19 Billion0.2% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $33.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...